Please use this identifier to cite or link to this item: http://adhlui.com.ui.edu.ng/jspui/handle/123456789/3073
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOmoniyi-Esan, G.O-
dc.contributor.authorBadmos, K.B-
dc.contributor.authorAdeyemi, A.B-
dc.contributor.authorRotimi, O-
dc.date.accessioned2024-10-10T13:10:04Z-
dc.date.available2024-10-10T13:10:04Z-
dc.date.issued2008-09-
dc.identifier.citationAfr J Med Med Sci 2008, 37(3): 285-288en_US
dc.identifier.issn1116-4077-
dc.identifier.urihttp://adhlui.com.ui.edu.ng/jspui/handle/123456789/3073-
dc.descriptionArticleen_US
dc.description.abstractLeiomyosarcomas of the uterus are highly malignant tumours that are rare and represent slightly over 1 % of all uterine malignancies. The clinical presentation is fairly constant and includes abnormal vaginal bleeding, pains or both. Only two cases (0.6%) out of 337 uterine malignancies seen over a period of 15 years in Ile-Ife had histological diagnosis of leiomyosarcoma. Both patients were postmenopausal, aged 49 years and presented in advanced disease stage. Two months after surgery, one of the patients died from disease progression while the other defaulted while on chemotherapy. Leiomyosarcoma of the uterus though rare in our environment, when it occurs, presents with advanced stage of the disease. Poor compliance coupled with high cost of treatment portends poor prognosis thus making it rapidly fatalen_US
dc.description.sponsorshipCOLLEGE OF MEDCINE, UNIVERSITY OF IBADANen_US
dc.language.isoenen_US
dc.publisherCOLLEGE OF MEDICINE, UNIVERSITY OF IBADANen_US
dc.subjectLeiomyosarcomaen_US
dc.subjectuterusen_US
dc.subjectpoor prognosisen_US
dc.titleLeiomyosarcoma of the uterus: a clinicopathological report of two cases and review of literature.en_US
dc.typeArticleen_US
Appears in Collections:African Journal of Medicine and Medical Sciences

Files in This Item:
File Description SizeFormat 
Omoniyi-Esan et al_Leiomyosarcoma_2008.pdfArticle7.52 MBAdobe PDFView/Open


Items in COMUI (ADHL) are protected by copyright, with all rights reserved, unless otherwise indicated.